These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34400274)

  • 1. Progress in drug formulation design and delivery of medicinal substances used in ophthalmology.
    Wróblewska KB; Jadach B; Muszalska-Kolos I
    Int J Pharm; 2021 Sep; 607():121012. PubMed ID: 34400274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic drug dosage forms: characterisation and research methods.
    Baranowski P; Karolewicz B; Gajda M; Pluta J
    ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
    Babizhayev MA; Kasus-Jacobi A
    Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies.
    Mofidfar M; Abdi B; Ahadian S; Mostafavi E; Desai TA; Abbasi F; Sun Y; Manche EE; Ta CN; Flowers CW
    Int J Pharm; 2021 Sep; 607():120924. PubMed ID: 34324989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical ocular drug delivery systems: Innovations for an unmet need.
    Yang Y; Lockwood A
    Exp Eye Res; 2022 May; 218():109006. PubMed ID: 35248559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular Drug Delivery System-based on Solid Nanoparticles].
    Nagai N
    Yakugaku Zasshi; 2021; 141(1):47-53. PubMed ID: 33390447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.
    Lanier OL; Manfre MG; Bailey C; Liu Z; Sparks Z; Kulkarni S; Chauhan A
    AAPS PharmSciTech; 2021 Mar; 22(3):107. PubMed ID: 33719019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact lenses as drug-delivery systems: a promising therapeutic tool.
    Holgado MA; Anguiano-Domínguez A; Martín-Banderas L
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):24-33. PubMed ID: 31420118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nanoparticles as drug delivery systems in ophthalmology].
    Löscher M; Hurst J; Strudel L; Spitzer MS; Schnichels S
    Ophthalmologe; 2018 Mar; 115(3):184-189. PubMed ID: 29110121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophthalmic drug delivery systems--recent advances.
    Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
    Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in ophthalmic drug delivery.
    Morrison PW; Khutoryanskiy VV
    Ther Deliv; 2014 Dec; 5(12):1297-315. PubMed ID: 25531930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.
    Xinming L; Yingde C; Lloyd AW; Mikhalovsky SV; Sandeman SR; Howel CA; Liewen L
    Cont Lens Anterior Eye; 2008 Apr; 31(2):57-64. PubMed ID: 17962066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glaucoma: Current treatment and impact of advanced drug delivery systems.
    Yadav KS; Rajpurohit R; Sharma S
    Life Sci; 2019 Mar; 221():362-376. PubMed ID: 30797820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent patents and advances in ophthalmic drug delivery.
    Janoria KG; Hariharan S; Dasari CR; Mitra AK
    Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery by contact lens in spontaneously glaucomatous dogs.
    Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
    Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the latest solutions in the use of contact lenses as controlled release systems for ophthalmic drugs.
    Stiler-Wyszyńska S; Golba S; Jurek-Suliga J; Kuczkowski S
    Polim Med; 2023; 53(1):47-58. PubMed ID: 36637332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ways to improve ocular bioavailability for topical applications].
    Sirbat D; Marchal-Heussler L; Hoffman M; Maincent P
    J Fr Ophtalmol; 2000 May; 23(5):505-9; quiz 523. PubMed ID: 10844314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.